Search

everythinglearnresearchcommunity

for

Search:↓

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

The extracts may help hair growth.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Black hairy tongue can be an early sign of graft-versus-host disease after stem cell transplants.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Alopecia areata may be linked to higher heart disease risk.

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Transepidermal drug delivery effectively treated areata alopecia with minimal side effects.

Pakis Gajah (Angiopteris evecta) water extract may promote hair growth in rabbits, but more research is needed for human use.

Oral minoxidil helped significantly regrow hair in a patient with traction alopecia.

Activating mitophagy may help manage a key immune response involved in the hair loss condition alopecia areata.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

Topical patches with garlic extract effectively release allicin for hair loss treatment.

Terminalia chebula fruit extract helps hair growth by reducing DHT and boosting hair cell activity.

2.5 mg/mL TAC is as effective and safe as 5 mg/mL, but 5 mg/mL may improve hair regrowth and density more.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Unani medicine helped regrow eyebrow hair in 45 days.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

People with severe Alopecia Areata have higher levels of TGF-β1, which may play a role in the condition.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Stopping the use of a tight headband and using specific treatments led to partial hair regrowth.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Trichoscopy is reliable for diagnosing Temporal Triangular Alopecia and can prevent unnecessary biopsies and wrong treatments.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Targeting mitophagy may help treat alopecia areata by reducing inflammasome activation.